BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 28, 2006
View Archived Issues
Snapshots of newly reported clinical trials in leukemia, myelodysplastic syndromes: I
Read More
PEP-005 activates neutrophils to reduce residual tumor cells
Read More
Progress in phase II study of bremelanotide in female sexual dysfunction
Read More
MBX-2044 begins proof-of-concept phase IIa study for diabetes
Read More
Heplisav begins pivotal phase III study for hepatitis B
Read More
Hana requests SPA for pivotal Marqibo study in ALL
Read More
Altus and Genentech sign agreement for ALTU-238
Read More
Kosan and Pfizer sign worldwide license agreement for motilin agonist program
Read More
Enrollment completed in phase II study of faropenem for acute otitis media
Read More
APF-530 NDA filing delayed
Read More
EndoTAG-1 shows good safety and preliminary efficacy in pancreatic cancer
Read More
Proellex improves bleeding and pain in uterine fibroid patients
Read More
NCI begins new studies of ispinesib
Read More
iCo files IND for iCo-007 for the treatment of eye diseases
Read More
Tibotec files to begin phase I testing of HCV NS3/4A protease inhibitor
Read More
GSK to acquire Praecis
Read More
NS-2359 begins phase II development for major depressive disorder
Read More
Panacos files IND for second-generation HIV maturation inhibitor PA-1050040
Read More
Safety, tolerability and efficacy of single- and multiple-dose norclozapine shown in phase II trials
Read More
L-type calcium channel modulator MEM-1003 enhances cognitive activity in rodents
Read More
Mycamine sNDA filed for candidemia and Candida infections
Read More
New agents for cancer covered in recent patent literature
Read More
Approvable letter for Altabax in secondarily infected traumatic lesions
Read More
Xcytrin filed for NSCLC patients with brain metastases
Read More
Byetta receives FDA approval
Read More
Recent patents report novel therapeutic agents for asthma, allergy, etc.
Read More
Junovan NDA accepted for review
Read More